Trial Profile
A Study of Cardiac Repolarization Effects, Pharmacokinetics, and Safety of TH-302 in Patients with Advanced Cancer
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2014
Price :
$35
*
At a glance
- Drugs Evofosfamide (Primary)
- Indications Solid tumours
- Focus Pharmacodynamics
- 14 Jan 2014 New trial record